Apollo Therapeutics Holds USD33.5M Second Close of Series C; Brings Round Total to $260M

Apollo Therapeutics, a Cambridge, UK and Boston, MA- and and Chicago, IL-based portfolio biopharmaceutical company focused on translating fundamental medical research into medicines, raised USD 33.5M in a second close of its Series C financing.

The round, which brought the total amount to $260M, was led by Patient Square Capital and included participation by multiple new investors including M&G plc and two of the largest US public pension plans, along with existing investors including Rock Springs Capital.

The company intends to use the funds to advance pipeline programs through clinical development and further fund its drug discovery and development activities based on breakthroughs in basic medical research made at its partner institutions, license or acquire additional clinical stage programs that meet strict selection criteria.

Led by CEO Dr. Richard Mason, Apollo Therapeutics is a portfolio biopharmaceutical company focused on translating fundamental medical research into medicines. The portfolio-model is built around a centralized management team of capital allocators and functional leaders with deep expertise in pharmaceutical R&D, manufacturing, commercial strategy, fund-raising, and business development, leveraged over a diverse portfolio of therapeutic programs, each led by a dedicated and seasoned asset leader.

Congratulations, Apollo! What an impressive achievement with the second close of Series C, reaching a total of $260M. Your leadership has undoubtedly played a crucial role in this success. Well done!

~ Dr Shishir said Gupta founder & CEO of StartupLanes 

About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.

Startups looking for funding may apply through StartupLanes Funding Application.

Angel Investors Register Free to explore exciting startup investment opportunities.

Scroll to Top